CIK 2088557
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 52.09% | 20 |
| Health Care Equipment & Supplies | 37.85% | 9 |
| Distributors | 6.46% | 1 |
| Health Care Providers & Services | 3.60% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Health Care | 7.35% |
| 2 | HSIC | HENRY SCHEIN INC | Consumer Discretionary | 6.46% |
| 3 | BDX | BECTON DICKINSON & CO | Health Care | 6.16% |
| 4 | PTCT | PTC THERAPEUTICS, INC. | Health Care | 5.77% |
| 5 | DXCM | DEXCOM INC | Health Care | 4.75% |
| 6 | ICUI | ICU MEDICAL INC/DE | Health Care | 4.61% |
| 7 | INSM | INSMED Inc | Health Care | 4.48% |
| 8 | ISRG | INTUITIVE SURGICAL INC | Health Care | 4.38% |
| 9 | RVMD | Revolution Medicines, Inc. | Health Care | 4.31% |
| 10 | GMED | GLOBUS MEDICAL INC | Health Care | 4.29% |
31/31 names classified · sector 100.0% of weight · industry 100.0% · mkt cap 98.3%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 100.0% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 66.0% of book weight (16/31 names) · unclassified 34.0%: INSM, RVMD, DNLI, OLMA, ELAN, EVMN, TNDM, COGT, NUVL, OCUL +5 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ZBHZIMMER BIOMET HOLDINGS INC | 579,161 | $52M | 7.4% | NEW |
| 2 | HSICHENRY SCHEIN INC | 624,037 | $46M | 6.5% | ADD 95% |
| 3 | BDXBECTON DICKINSON & CO | 279,210 | $44M | 6.2% | ADD 244% |
| 4 | PTCTPTC THERAPEUTICS INC | 376,165 | $41M | 5.8% | NEW |
| 5 | DXCMDEXCOM | 538,762 | $34M | 4.8% | ADD 120% |
| 6 | ICUIICU MED INC | 254,291 | $33M | 4.6% | TRIM −25% |
| 7 | INSMINSMED INC | 194,909 | $32M | 4.5% | ADD 290% |
| 8 | ISRGINTUITIVE SURGICAL INC | 67,681 | $31M | 4.4% | ADD 48% |
| 9 | RVMDREVOLUTION MEDICINES INC | 315,972 | $31M | 4.3% | TRIM −13% |
| 10 | GMEDGLOBUS MED INC | 354,350 | $31M | 4.3% | ADD 33% |
| 11 | NBIXNEUROCRINE BIOSCIENCES INC | 209,932 | $28M | 3.9% | NEW |
| 12 | DNLIDENALI THERAPEUTICS INC | 1,359,969 | $26M | 3.7% | ADD 107% |
| 13 | PACSPACS GROUP INC | 604,180 | $26M | 3.6% | TRIM −47% |
| 14 | OLMAOLEMA PHARMACEUTICALS INC | 1,504,536 | $22M | 3.1% | ADD 22% |
| 15 | ELANELANCO ANIMAL HEALTH INC | 931,121 | $22M | 3.1% | ADD 132% |
| 16 | PFEPFIZER INC | 1,464,129 | $19M | 2.7% | TRIM −34% |
| 17 | LLYELI LILLY & CO | 20,696 | $19M | 2.7% | TRIM −35% |
| 18 | LNTHLANTHEUS HLDGS INC | 249,401 | $19M | 2.7% | NEW |
| 19 | ITGRINTEGER HLDGS CORP | 213,027 | $19M | 2.6% | NEW |
| 20 | BIIBBIOGEN INC | 96,289 | $18M | 2.5% | TRIM −41% |
| 21 | EVMNEVOMMUNE INC | 678,589 | $16M | 2.2% | ADD 215% |
| 22 | TNDMTANDEM DIABETES CARE INC | 761,905 | $15M | 2.1% | NEW |
| 23 | COGTCOGENT BIOSCIENCES INC | 352,590 | $14M | 1.9% | TRIM −38% |
| 24 | NUVLNUVALENT INC | 129,950 | $13M | 1.9% | TRIM −52% |
| 25 | OCULOCULAR THERAPEUTIX INC | 1,487,645 | $13M | 1.8% | ADD 118% |
| 26 | ASNDASCENDIS PHARMA A/S | 51,895 | $12M | 1.7% | TRIM −39% |
| 27 | ALGNALIGN TECHNOLOGY INC | 67,332 | $12M | 1.6% | TRIM −47% |
| 28 | ELDNELEDON PHARMACEUTICALS INC | 3,564,127 | $11M | 1.5% | ADD 8% |
| 29 | ORICORIC PHARMACEUTICALS INC | 842,928 | $11M | 1.5% | NEW |
| 30 | BHVNBIOHAVEN LTD | 315,944 | $3M | 0.4% | NEW |
| 31 | MREOMEREO BIOPHARMA GROUP PLC | 7,558,756 | $2M | 0.4% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| ZBHZIMMER BIOMET HOLDINGS INC | — | — | — | — | — | 579K | $52M |
| HSICHENRY SCHEIN INC | — | — | — | — | 320K | 624K | $46M |
| BDXBECTON DICKINSON & CO | — | — | — | — | 81K | 279K | $44M |
| PTCTPTC THERAPEUTICS INC | — | — | — | — | — | 376K | $41M |
| DXCMDEXCOM | — | — | — | — | 245K | 539K | $34M |
| ICUIICU MED INC | — | — | — | — | 341K | 254K | $33M |
| INSMINSMED INC | — | — | — | — | 50K | 195K | $32M |
| ISRGINTUITIVE SURGICAL INC | — | — | — | — | 46K | 68K | $31M |
| RVMDREVOLUTION MEDICINES INC | — | — | — | — | 363K | 316K | $31M |
| GMEDGLOBUS MED INC | — | — | — | — | 267K | 354K | $31M |
| NBIXNEUROCRINE BIOSCIENCES INC | — | — | — | — | — | 210K | $28M |
| DNLIDENALI THERAPEUTICS INC | — | — | — | — | 657K | 1.4M | $26M |
| PACSPACS GROUP INC | — | — | — | — | 1.1M | 604K | $26M |
| OLMAOLEMA PHARMACEUTICALS INC | — | — | — | — | 1.2M | 1.5M | $22M |
| ELANELANCO ANIMAL HEALTH INC | — | — | — | — | 401K | 931K | $22M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
